{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:13:20Z","timestamp":1793884400234,"version":"4.7.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.urolonc.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T15:47:44Z","timestamp":1706802464000},"page":"69.e17-69.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-1561","authenticated-orcid":false,"given":"Annamaria","family":"Porreca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Di Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-1229","authenticated-orcid":false,"given":"Giuseppe","family":"Lucarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vartolomei Mihai","family":"Dorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4296-429X","authenticated-orcid":false,"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Alessandro","family":"Mistretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Luzzago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Buonerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cantiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Veccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Musi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Hurle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7291-0316","authenticated-orcid":false,"given":"Gian Maria","family":"Busetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisto","family":"Perdon\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Del","family":"Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Bove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Crisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4687-7353","authenticated-orcid":false,"given":"Giorgio Ivan","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Damiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Amparore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Porpiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7045-7725","authenticated-orcid":false,"given":"Riccardo","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Piccinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Brescia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7057-7815","authenticated-orcid":false,"given":"Sabin Octavian","family":"T\u0103taru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4315-7660","authenticated-orcid":false,"given":"Felice","family":"Crocetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo Lo","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottavio","family":"de Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Schips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-4127","authenticated-orcid":false,"given":"Michele","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.01.001_bib0001","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/bco2.120","article-title":"Long-term outcomes of outpatient laser ablation for recurrent non-muscle invasive bladder cancer: a retrospective cohort study","volume":"3","author":"Grover","year":"2021","journal-title":"BJUI Compass"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.001_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23736\/S2724-6051.21.04613-9","article-title":"Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic?","volume":"74","author":"Paciotti","year":"2022","journal-title":"Minerva Urol Nephrol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.001_bib0003","first-page":"796","article-title":"Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study","volume":"73","author":"Ferro","year":"2021","journal-title":"Minerva Urol Nefrol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.001_bib0004","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.euf.2020.07.002","article-title":"Nomogram predicting bladder cancer-specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consortium","volume":"7","author":"Mir","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0005","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.euf.2021.07.015","article-title":"Survival outcomes after immediate radical cystectomy versus conservative management with Bacillus Calmette-Gu\u00e9rin among T1 high-grade micropapillary bladder cancer patients: results from a multicentre collaboration","volume":"8","author":"Lonati","year":"2022","journal-title":"Eur Urol Focus"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.001_bib0006","doi-asserted-by":"crossref","first-page":"292","DOI":"10.23736\/S2724-6051.21.04309-5","article-title":"Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era","volume":"73","author":"Albisinni","year":"2021","journal-title":"Minerva Urol Nephrol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0007","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00345-020-03474-8","article-title":"Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions","volume":"39","author":"Pfail","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2217\/fon-2019-0817","article-title":"KEYNOTE-676: phase III study of BCG and pembrolizumab for persistent\/recurrent high-risk NMIBC","volume":"16","author":"Kamat","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0009","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1200\/JCO.2011.34.6056","article-title":"Overall survival as the outcome for randomized clinical trials with effective subsequent therapies","volume":"29","author":"Korn","year":"2011","journal-title":"JCO"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0010","first-page":"1121","article-title":"Clinical endpoints in oncology - a primer","volume":"11","author":"Delgado","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0012","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2217\/fon-2021-0273","article-title":"Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: phase III KEYNOTE-866 and KEYNOTE-905\/EV-303","volume":"17","author":"Galsky","year":"2021","journal-title":"Future Oncol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0013","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines","author":"Alfred Witjes","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0015","doi-asserted-by":"crossref","first-page":"e3539","DOI":"10.1097\/MD.0000000000003539","article-title":"Clinical significance of the prognostic nutritional index for predicting short- and long-term surgical outcomes after gastrectomy: a retrospective analysis of 7781 gastric cancer patients","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.001_bib0016","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/diagnostics12030586","article-title":"Modified glasgow prognostic score as a predictor of recurrence in patients with high grade non-muscle invasive bladder cancer undergoing intravesical Bacillus Calmette\u2013Guerin immunotherapy","volume":"12","author":"Ferro","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.clgc.2016.04.008","article-title":"The clinical use of the neutrophil to lymphocyte ratio (NLR) in urothelial cancer: a systematic review","volume":"14","author":"Marchioni","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0018","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.euo.2018.06.006","article-title":"Systemic inflammatory markers and oncologic outcomes in patients with high-risk non\u2013muscle-invasive urothelial bladder cancer","volume":"1","author":"Cantiello","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0019","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1200\/JCO.2017.73.9987","article-title":"Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer","volume":"35","author":"Xie","year":"2017","journal-title":"JCO"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12874-021-01386-8","article-title":"A comparative study of forest methods for time-to-event data: variable selection and predictive performance","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0021","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12911-019-0801-4","article-title":"Predicting factors for survival of breast cancer patients using machine learning techniques","volume":"19","author":"Ganggayah","year":"2019","journal-title":"BMC Med Inf Decis Making"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0022","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of guarantee-time bias","volume":"31","author":"Giobbie-Hurder","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0023","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12874-017-0405-6","article-title":"Statistical methods for elimination of guarantee-time bias in cohort studies: a simulation study","volume":"17","author":"Cho","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0024","unstructured":"Kohn M, Senyak J. Sample size \u2013 survival analysis | Sample size calculators. Sample size calculators for designing clinical research 2023. https:\/\/sample-size.net\/sample-size-survival-analysis\/ (accessed April 29, 2023)."},{"key":"10.1016\/j.urolonc.2024.01.001_bib0025","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1200\/JCO.2015.64.4070","article-title":"Definitions, end points, and clinical trial designs for non\u2013muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group","volume":"34","author":"Kamat","year":"2016","journal-title":"JCO"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0026","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.eururo.2015.02.040","article-title":"Maintenance therapy with 3-monthly Bacillus Calmette-Gu\u00e9rin for 3 years is not superior to standard induction therapy in high-risk non\u2013muscle-invasive urothelial bladder carcinoma: final results of randomised CUETO Study 98013","volume":"68","author":"Mart\u00ednez-Pi\u00f1eiro","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.001_bib0027","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40291-023-00679-6","article-title":"How do molecular classifications affect the neoadjuvant treatment of muscle-invasive urothelial carcinoma?","volume":"28","author":"Conci","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0028","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0029","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1016\/S1470-2045(23)00321-2","article-title":"Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed","volume":"24","author":"Jena","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/oncolo\/oyac006","article-title":"Surrogacy Beyond prognosis: the importance of \u201ctrial-level\u201d surrogacy","volume":"27","author":"Buyse","year":"2022","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.001_bib0031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.23736\/S0393-2249.18.03309-X","article-title":"Bacillus Calmette-Gu\u00e9rin unresponsiveness in non-muscle-invasive bladder cancer patients: what the urologists should know","volume":"71","author":"Moschini","year":"2019","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.urolonc.2024.01.001_bib0032","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11912-022-01350-9","article-title":"Novel therapies for high-risk non-muscle invasive bladder cancer","volume":"25","author":"Al Hussein Al Awamlh","year":"2023","journal-title":"Curr Oncol Rep"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:28:27Z","timestamp":1761042507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1078143924000036"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}